[L-dopa and Parkinson's disease].
D000284:Administration, Oral; D001812:Blood-Brain Barrier; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D007275:Injections, Intravenous; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D004295:Dihydroxyphenylalanine
L-dopa et maladie de Parkinson.